510(k) K124006

ILLUMINA MISEQDX CYSTIC FIBROSIS 139-VARIANT ASSAY by Illumina, Inc. — Product Code PFR

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
November 19, 2013
Date Received
December 26, 2012
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mutations & Variants Panel Sequencing Detection
Device Class
Class II
Regulation Number
866.5900
Review Panel
PA
Submission Type

The CFTR gene mutation detection system is used to simultaneously detect and identify a specified panel of mutations and variants in the CFTR gene using sequencing methods. It is intended for carrier screening, as an aid in confirmatory diagnostic testing of individuals with suspected cystic fibrosis (CF), and as an initial test to aid in the diagnosis of individuals with suspected CF. It is not intended for stand-alone diagnostic purposes, prenatal diagnostic, or pre-implantation screening.